Overview

Genetic Determinants of Opioids Analgesia

Status:
Completed
Trial end date:
1969-12-31
Target enrollment:
0
Participant gender:
All
Summary
The response to opioids varies greatly among individuals. Some of these variability is accounted for by genetic factors. The present study was designed to evaluate the possibility that genetic polymorphism in the gene encoding for mu opioid receptor may explain variability in the response to alfentanil during lithotripsy.
Phase:
N/A
Accepts Healthy Volunteers?
No
Details
Lead Sponsor:
Hadassah Medical Organization
Treatments:
Alfentanil
Criteria
Inclusion Criteria:

- Age > 20

Exclusion Criteria:

- Regular use of opioid drugs

- Known hypersensitivity to alfentanil